Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons

Endocrine

Volumn 43, Issue 2, 2013, Pages 334-341

  Kawamoto, Ryuichi ^a,b   Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Kusunoki, Tomo ^a   Abe, Masanori ^a   Katoh, Tateaki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

Hematocrit; HOMA IR; Insulin resistance; Metabolic syndrome

Indexed keywords

ADIPONECTIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; URIC ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COMMUNITY LIVING; ERYTHROCYTE COUNT; FEMALE; GENDER; HEALTH STATUS; HEMATOCRIT; HUMAN; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SMOKING HABIT;

EID: 84879552916     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9662-7     Document Type: Article

References (41)

1. A.M. McNeill, W.D. Rosamond, C.J. Girman, S.H. Golden, M.I. Schmidt, H.E. East, C.M. Ballantyne, G. Heiss, The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28, 385-390 (2005)
2. H.M. Lakka, D.E. Laaksonen, T.A. Lakka, L.K. Niskanen, E. Kumpusalo, J. Tuomilehto, J.T. Salonen, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709-2716 (2002)
3. K. Shiwaku, A. Nogi, K. Kitajima, E. Anuurad, B. Enkhmaa, M. Yamasaki, J.M. Kim, I.S. Kim, S.K. Lee, T. Oyunsuren, Y. Yamane, Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J. Occup. Health 47, 126-135 (2005)
4. F.S. Facchini, M. Carantoni, J. Jeppesen, G.M. Reaven, Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 47, 831-835 (1998)
5. V. Zídek, A. Fucíková, A. Musilová, V. Bílá, V. Kren, M. Pravenec, Hematocrit and hemoglobin values are negatively correlated with insulin resistance in spontaneous hypertension. Folia Biol. 45, 247-251 (1999)
6. M. Barbieri, E. Ragno, E. Benvenuti, G.A. Zito, A. Corsi, L. Ferrucci, G. Paolisso, New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 44, 1232-1237 (2001)
7. V.C. Ellinger, L.T. Carlini, R.O. Moreira, R.M. Meirelles, Relation between insulin resistance and hematological parameters in a Brazilian sample. Arg. Bras. Endocrinol. Metabol. 50, 114-117 (2006)
8. M.K. Tulloch-Reid, R.L. Hanson, A. Saremi, H.C. Looker, D.E. Williams, J. Krakoff, W.C. Knowler, Hematocrit and the incidence of type 2 diabetes in the pima indians. Diabetes Care 27, 2245-2246 (2004)
9. V. Lohsoonthorn, W. Jiamjarasrungsi, M.A. Williams, Association of hematological parameters with clustered components of metabolic syndrome among professional and office workers in Bangkok, Thailand. Diabetes Metab. Syndr. 1, 143-149 (2007)
10. Y.Y. Wang, S.Y. Lin, P.H. Liu, B.M. Cheung, W.A. Lai, Association between hematological parameters and metabolic syndrome components in a Chinese population. J. Diabetes Complicat. 18, 322-327 (2004)
11. J.D. Lin, W.K. Chiou, H.Y. Chang, F.H. Liu, H.F. Weng, T.H. Liu, Association of hematological factors with components of the metabolic syndrome in older and younger adults. Aging Clin. Exp. Res. 18, 477-484 (2006)
12. S.P. Perrine, M.F. Greene, P.D. Lee, R.A. Cohen, D.V. Faller, Insulin stimulates cord blood erythroid progenitor growth: evidence for an aetiological role in neonatal polycythaemia. Br. J. Haematol. 64, 503-511 (1986)
13. A.D. Baron, Hemodynamic actions of insulin. Am. J. Physiol. 267, E187-E202 (1994)
14. J.S. Floras, G. Meneilly, Insulin-mediated blood flow and glucose uptake. Can. J. Cardiol. 17, 7A-10A (2001)
15. R. Kawamoto, K. Kohara, Y. Tabara, T. Miki, N. Ohtsuka, T. Kusunoki, N. Yorimitsu, An association between body mass index and estimated glomerular filtration rate. Hypertens. Res. 31, 1559-1564 (2008)
16. R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, T. Kusunoki, S. Takayama, M. Abe, T. Katoh, N. Ohtsuka, Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine (submitted)
17. R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, M. Abe, T. Kusunoki, Increased high-density lipoprotein cholesterol is associated with a high prevalence of prehypertension and hypertension in community-dwelling persons. Endocrine 42, 321-328 (2012)
18. W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502 (1972)
19. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985)
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486-2497 (2001)
21. K.M. Choi, J. Lee, Y.H. Kim, K.B. Kim, D.L. Kim, S.G. Kim, D.H. Shin, N.H. Kim, I.B. Park, D.S. Choi, S.H. Baik, Koreans-Southwest Seoul (SWS) study, Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study. Diabetes Res. Clin. Pract. 60, 205-212 (2003)
22. A.J. Hanley, R. Retnakaran, Y. Qi, H.C. Gerstein, B. Perkins, J. Raboud, S.B. Harris, B. Zinman, Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J. Clin. Endocrinol. Metab. 94, 3824-3832 (2009)
23. R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, T. Kusunoki, S. Takayama, M. Abe, Hemoglobin is associated with serum high molecular weight adiponectin in Japanese community-dwelling persons. J. Atheroscler. Thromb. 18, 182-189 (2011)
24. J.G. Yu, S. Javorschi, A.L. Hevener, Y.T. Kruszynska, R.A. Norman, M. Sinha, J.M. Olefsky, The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51, 2968-2974 (2002)
25. M. Furuhashi, N. Ura, K. Higashiura, H. Murakami, M. Tanaka, N. Moniwa, D. Yoshida, K. Shimamoto, Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42, 76-81 (2003)
26. J.P. Gonçalves, A. Oliveira, M. Severo, A.C. Santos, C. Lopes, Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 41, 450-457 (2012)
27. T. Wang, Y. Bi, M. Xu, Y. Huang, Y. Xu, X. Li, W. Wang, G. Ning, Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 40, 109-116 (2011)
28. Y. Xu, M. Xu, Y. Huang, T. Wang, M. Li, Y. Wu, A. Song, X. Li, Y. Bi, G. Ning, Elevated serum γ-glutamyltransferase predicts the development of impaired glucose metabolism in middle-aged and elderly Chinese. Endocrine 40, 265-272 (2011)
29. Y. Tabara, H. Osawa, R. Kawamoto, R. Tachibana-Iimori, M. Yamamoto, J. Nakura, T. Miki, H. Makino, K. Kohara, Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J. Clin. Endocrinol. Metab. 93, 715-722 (2008)
30. I. Majumdar, L.D. Mastrandrea, Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine 41, 442-449 (2012)
31. X. Xiao, Y. Dong, J. Zhong, R. Cao, X. Zhao, G. Wen, J. Liu, Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose. Endocrine 40, 386-393 (2011)
32. L. Jia, C. Bonaventura, J. Bonaventura, J.S. Stamler, S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380, 221-226 (1996)
33. A. Sonmez, M.I. Yilmaz, M. Saglam, S. Kilic, T. Eyileten, G. Uckaya, K. Caglar, Y. Oguz, A. Vural, M. Yenicesu, M. Kutlu, C. Kinalp, C. Zoccali, The relationship between hemoglobin levels and endothelial functions in diabetes mellitus. Clin. J. Am. Soc. Nephrol. 5, 45-50 (2010)
34. A. Natali, E. Toschi, S. Baldeweg, A. Casolaro, S. Baldi, A.M. Sironi, J.S. Yudkin, E. Ferrannini, Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur. Heart J. 26, 464-471 (2005)
35. M. Kutlu, A. Sonmez, H. Genc, G. Erdem, S. Tapan, G. Celebi, C. Haymana, A. Taslipinar, G. Uckaya, M.K. Erbil, Relationship between hemoglobin and CD40 ligand in prediabetes. Clin. Invest. Med. 32, E244 (2009)
36. B. Pamukcu, G.Y. Lip, V. Snezhitskiy, E. Shantsila, The CD40-CD40L system in cardiovascular disease. Ann. Med. 43, 331-340 (2011)
37. A. Missiou, D. Wolf, I. Platzer, S. Ernst, C. Walter, P. Rudolf, K. Zirlik, N. Köstlin, F.K. Willecke, C. Münkel, U. Schönbeck, P. Libby, C. Bode, N. Varo, A. Zirlik, CD40L induces inflammation and adipogenesis in adipose cells - a potential link between metabolic and cardiovascular disease. Thromb. Haemost. 103, 788-796 (2010)
38. G. Nordby, A. Moan, S.E. Kjeldsen, I. Os, Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women. Am. J. Hypertens. 8, 439-444 (1995)
39. G. de Simone, R.B. Devereux, S. Chien, M.H. Alderman, S.A. Atlas, J.H. Laragh, Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81, 107-117 (1990)
40. F.S. Facchini, R.A. Stoohs, G.M. Reaven, Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am. J. Hypertens. 9, 1013-1017 (1996)
41. H.L. Aguila, Regulation of hematopoietic niches by sympathetic innervation. Bioassays 28, 687-691 (2006)